Showing 1 - 9 of 9
Persistent link: https://www.econbiz.de/10003929591
"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. We estimate the impact of diabetic drug adherence on hospitalizations, ER visits, and hospital costs, using insurance claims from...
Persistent link: https://www.econbiz.de/10003933934
Persistent link: https://www.econbiz.de/10008648677
Persistent link: https://www.econbiz.de/10008655672
"Private insurance for prescription drugs is characterized by two regimes: flat copayments and variable co-insurance. We develop a simple model to show that patient compliance is lower under coinsurance due to uncertainty in cost-sharing. Empirically, we derive comparable models for compliance...
Persistent link: https://www.econbiz.de/10002225444
We estimate the impact of diabetic drug adherence on hospitalizations, ER visits, and hospital costs, using insurance claims from MarketScan® employer data. However, it is often difficult to measure the impact of drug adherence on hospitalizations since both adherence and hospitalizations may...
Persistent link: https://www.econbiz.de/10013148386
Insurance for prescription drugs is characterized by two types of cost-sharing: flat copayments and variable coinsurance. We develop a theoretical model to show that refill purchases of preventive drugs (compliance) are lower under coinsurance due to the consumer's exposure to variation in drug...
Persistent link: https://www.econbiz.de/10013322350
We estimate the impact of diabetic drug adherence on hospitalizations, ER visits, and hospital costs, using insurance claims from MarketScan® employer data. However, it is often difficult to measure the impact of drug adherence on hospitalizations since both adherence and hospitalizations may...
Persistent link: https://www.econbiz.de/10012462961
Insurance for prescription drugs is characterized by two types of cost-sharing: flat copayments and variable coinsurance. We develop a theoretical model to show that refill purchases of preventive drugs (compliance) are lower under coinsurance due to the consumer's exposure to variation in drug...
Persistent link: https://www.econbiz.de/10012467952